Member Info for WeTookPelham

? And some auto buys 10:03? Thoughts?
P.s. apologies for going off topic ;)

Hi TF and CC24601 ,
Something I can't work is, despite Scancells reservations for using the online/virtual platforms for attending those conferences (understandable as face to face is usually always preferable), did they actually attend virtually then or not?

Apologies if already posted:

https://www.ncbi.nlm.nih.gov/pubmed/32134278

https://www.drugtargetreview.com/news/60206/celltrion-selects-14-lead-monoclonal-antibodies-for-covid-19-treatment/

https://www.businesswire.com/news/home/20200413005181/en/%C2%A0Celltrion-Completes-Neutralisation-Test-Candidate-Monoclonal-Antibodies

https://www.fiercebiotech.com/biotech/gigagen-jumps-into-covid-19-arena-polyclonal-antibodies

https://www.biospace.com/article/vir-biotechnology-ids-2-monoclonal-antibodies-against-the-covid-19-coronavirus/

https://uk.reuters.com/article/uk-health-coronavirus-china-scientists/chinese-scientists-seeking-potential-covid-19-treatment-find-effective-antibodies-idUKKBN21J4R2

https://www.astrazeneca.com/media-centre/articles/2020/researching-antibodies-to-target-covid-19.html

C7, you say "Some of the rises we are seeing in the sector of late just wave red flags to me as to future direction these shares will take, perhaps i just feel mor comfortable for now sitting where we are. Lets hope for a blue day tomorrow, and if we should rise see a damned good reason for it. Goodningt guys, till tomorrow."

I think many of us here would take a similar sharp rise caused by speculation/rumour/no basis whatsoever...
Just IMO.

Something I forgot to say previously, could the radio sileince could be due to on-going negotiations?

Again Ivy, agree with you wholeheartedly with your Wed 08:40 post.

I personally (IMO) think the silence is of significance, either in a bad way or a good way...obviously hoping it's for a good reason! As there is (IMO) no way Scancell haven't been impacted and/or are contributing to the tackling Corona Virus, either using their current know how/products (avidimab the obvious one?) or adapting what they have...again all IMO.

For those of you you email the board, has anyone heard anything recently, if not anyone care to send a quick email simply asking how is the company is being (and has been) affected by the corona virus.

P.S. what's the email everyone uses to contact again?
P.P.S. 5.50p paid earlier?

https://www.wallstreetreporter.com/2020/04/gilead-is-said-to-hold-arcus-stake-talks-spurring-54-rally/

https://www.arcusbio.com/about-us/

@Ivyspivey - agree with your 15:34 post.
"...I just find it surprising that no news whatsoever" - This...100%! Any kind of update would be nice, and yes pharma/biotech sentiment is so high atm and yet Scancell somehow still manages to languish.

https://www.bloomberg.com/news/articles/2020-04-14/astra-to-test-cancer-medicine-for-lethal-covid-19-reaction

Now this is interesting...

Have they been mentioned on here before?

https://www.nottingham.ac.uk/news/cancer-survivor-funds-groundbreaking-study-to-find-out-why-cancer-returns-in-some-patients-and-not-others

"...We are particularly excited to be part of the Continuum family as it allows us understand why some patients respond very well to treatment and become long term cancer survivors. As part of this project we have already identified novel targets and unique immune receptors which we believe may be important in the long term survival of several cancer patients. We can now use these receptors to target these proteins in other less fortunate cancer patients. We also integrate closely with other Continuum members from other Universities who are focusing on other aspects of cancer biology in long term cancer survivors.
Professor of Cancer immunotherapy, Lindy Durrant at the University of Nottingham"

RE the burn rate/expenditure, if trail commencment has been temporarily paused and staff being paid via the furlough 80% scheme then the burn rate should be should be very low should it not?

https://scienceblog.cancerresearchuk.org/2020/04/07/opinion-today-our-researchers-are-helping-to-beat-covid-19-so-that-tomorrow-we-can-get-back-to-beating-cancer/

https://www.cancerresearchuk.org/funding-for-researchers/research-features/2020-04-06-covid-19-open-letter-to-cancer-researchers

"...Cancer Research UK institutes and laboratories are repurposing their resources to help the COVID-19 response"

Being a charity they'll a have a different remit to Scancell and other "private" bio companies I guess, but interesting nonetheless?

So well over a month since the last tweet/rns, I still find it puzzling that since the outbreak of Corona and it being arguably one of the biggest impacts on the world ever, we have nothing from Scancell about its impact on them?

So either it's business as usual which seems a little odd, or as inferred by others maybe they have some involvement in covid19 via avidimab??
But either way...I'm just a little bemused still by the lack of communication here, is it just me that feels that?

https://www.bbc.co.uk/news/health-52235467

Ah apologies, didn't realise Tiziana were British!
Could the first agreement be them in that case?
https://www.investegate.co.uk/scancell-hlds--sclp-/rns/first-collaboration-agreement-for-avidimab/201909040700061118L/

Very interesting (and good post) RayP, thanks. Again re-empasises wha's been said that Scancell may have apart to play in Covid19 after all?

I can't work out if Tiziana are solely an antibody company? https://www.tizianalifesciences.com/about-us/
Their anti-body product(s?):
"...Foralumab
Foralumab is a fully human anti-CD3 monoclonal antibody (mAb) for the treatment of NASH, Crohn’ s Disease and as a neurodegenerative indicator. It has completed Phase 2 studies in Crohn’s disease. Foralumab has demonstrated ability to activate regulatory T cells that systemically circulate to elicit targeted immunomodulation providing therapeutic benefit to patients."

And Scancells third agreement for Avidimab.... could it possibly be Tiziana.....?

https://www.investegate.co.uk/scancell-hlds--sclp-/rns/third-agreement-signed-for-antibody-platform/202001200700052382A/
"...Scancell, the developer of novel immunotherapies for the treatment of cancer, is pleased to announce that it has signed a collaboration and non-exclusive research agreement with a US-based, clinical stage antibody company to assess monoclonal antibodies (mAbs) targeting tumour-associated glycans (TaGs) including those that have been enhanced with Scancell's proprietary AvidiMab™ technology."

@Chester your earlier post:
"...Scancell are the experts in 'Binding' so any Pharma or Bio company using Mabs can use AvidMab as a gear change in potency, for any medical purpose. Which would include CV-19 research, it's a possibily and that's all it is"

"...Scancells expertise and proprietary technology is not solely bound by the realms or cancer treatment."

This is what I was trying to establish/understand before so thanks for that, makes sense.

Also, unrelated but whats going on with the spread atm?

Crumbs/Baerno1... agreee with your posts and it was what I was alluding to recently. Surely Covid19 has had some impact on operations? But yes good point Balerno1, perhaps something is brewing hence the radio silence???

And just a reminder no RNS since 03 March RE the 3 x conference attendences and no tweets since about then either.

Just to add to my previous post, here's the paper - https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(20)30118-3.pdf

https://www.independent.co.uk/news/science/coronavirus-vaccine-pittsburgh-university-lancet-study-covid-pandemic-a9442536.html

"...To increase potency, the researchers also used a new drug delivery approach involving of a fingertip-sized patch of 400 tiny microneedles that inject the spike protein pieces into the skin, where the immune reaction is strongest. The patch is stuck on like a plaster and the needles – which are made entirely of sugar and the protein pieces – simply dissolve into the skin."
Curious to here peoples thoughts on this?

Also, whilst I appreciate Virilogy is a distinctly different branch of science, something i wondered was are "any" of the skills/products/knowledge/experience/technology/expertise that Scancell have transferable to Covid19 research? I'm just curious as a) they've been very quiet of late and maybe have been helping in some way? and b) I would have thought there was a concerted effort by whole scientific community to help look for a solution to Covid19?